Results 291 to 300 of about 1,109,482 (395)

Newly Reported Chronic Hepatitis C Among Adults - Alaska, 2016-2023. [PDF]

MMWR Morb Mortal Wkly Rep
Scobie HM, Allison J, Masters N, Toomey M, Blake I, Johnston JM, Teshale E, Lawrence R, Ohlsen E, Bruden D, Fischer M, McLaughlin J.   +11 more
europepmc   +1 more source

Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection

Alimentary Pharmacology and Therapeutics, 2014
R. Koff
semanticscholar   +1 more source

Evaluation of portal venous flow velocity before and after direct acting antiviral therapy in chronic hepatitis C: A cohort study. [PDF]

Medicine (Baltimore)
Çolakoğlu Er H, Er RE, Yildirim AE.
europepmc   +1 more source

Autoantibodies and hepatitis C virus genotypes in chronic hepatitis C patients in Estonia

, 2005
Eva Žusinaite
openalex   +1 more source

Liver Stiffness Measurements After Oral Antivirals Effectively Predict the Risk of HCC in Patients With Chronic Hepatitis C. [PDF]

J Gastroenterol Hepatol
Lee YR, Woo HY, Kweon YO, Tak WY, Jang SY, Park JG, Kang MK, Song JE, Jang BK, Lee C, Kim BS, Hwang JS, Chung WJ, Heo J, Heo NY, Park SH, Yoon JS, Jeong J, Kwak SG, Kang Y, Baek YH, Park SY.   +21 more
europepmc   +1 more source

Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients

, 2007
Toru Ishikawa
openalex   +2 more sources

Impact of Direct-Acting Antivirals on Extrahepatic Manifestations in Chronic Hepatitis C: A Narrative Review with a Hermeneutic Approach. [PDF]

Healthcare (Basel)
Balta AAS, Ignat MD, Barbu RE, Dumitru C, Radaschin DS, Bulza V, Mateescu Costin SA, Pleșea-Condratovici C, Baroiu L.   +8 more
europepmc   +1 more source

Direct-acting antiviral treatment significantly shaped the gut microbiota in chronic hepatitis C patients: a pilot study. [PDF]

Front Microbiol
Elsherbiny NM, Kamal El-Din OM, Hassan EA, Hetta HF, Alatawy R, Sayed Ali MA, Alanazi FE, Abdel-Maksoud MS, Aljohani HM, Badary MS, Mahran ZG, Kresha MA, Bakr KA, Abdelwahab H, Ramadan M.   +14 more
europepmc   +1 more source

PP-139 Efficacy of treatment with interferon alfa/ribavirin of patients with chronic viral hepatitis C in relation to GNB3 polymorphism

, 2010
L. Ziyakhanova, Erkin Musabaev, M. A. Abdukadirova, Aziza Khikmatullaeva   +3 more
openalex   +1 more source

Design and nonviral delivery of live attenuated vaccine to prevent chronic hepatitis C virus-like infection. [PDF]

Nat Commun
Trivedi S, Dravid P, Passchier TC, Murthy S, Kasudhan KS, Reguraman N, Kellar J, Chandra R, Cassady C, Burbelo PD, Grakoui A, Sharma H, Simmonds P, Kapoor A.   +13 more
europepmc   +1 more source